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COMMENTARY Open Access
The increasing chronicity of HIV in sub-Saharan
Africa: Re-thinking “HIV as a long-wave event”
in the era of widespread access to ART
Stephanie A Nixon1,2*, Jill Hanass-Hancock2, Alan Whiteside2 and Tony Barnett3,4
Abstract
HIV was first described as a “long-wave event” in 1990, well before the advent of antiretroviral therapy (ART). The
pandemic was then seen as involving three curves: an HIV curve, an AIDS curve and a curve representing societal
impact. Since the mid-2000’s, free public delivery of life-saving ART has begun shifting HIV from a terminal disease
to a chronic illness for those who can access and tolerate the medications. This increasing chronicity prompts
revisiting HIV as a long-wave event. First, with widespread availability of ART, the HIV curve will be higher and last
longer. Moreover, if patterns in sub-Saharan Africa mirror experiences in the North, people on ART will live far
longer lives but with new experiences of disability. Disability, broadly defined, can result from HIV, its related
conditions, and from side effects of medications. Individual experiences of disability will vary. At a population level,
however, we anticipate that experiences of disability will become a common part of living with HIV and,
furthermore, may be understood as a variation of the second curve. In the original conceptualization, the second
curve represented the transition to AIDS; in the era of treatment, we can expect a transition from HIV infection to
HIV-related disability for people on ART. Many such individuals may eventually develop AIDS as well, but after a
potentially long life that includes fluctuating episodes of illness, wellness and disability. This shift toward chronicity
has implications for health and social service delivery, and requires a parallel shift in thinking regarding HIV-related
disability. A model providing guidance on such a broader understanding of disability is the World Health
Organization’s International Classification of Functioning, Disability and Health (ICF). In contrast to a biomedical
approach concerned primarily with diagnoses, the ICF includes attention to the impact of these diagnoses on
people’s lives and livelihoods. The ICF also focuses on personal and environmental contextual factors. Locating
disability as a new form of the second curve in the long-wave event calls attention to the new spectrum of needs
that will face many people living with HIV in the years and decades ahead.
HIV as a long-wave event
“HIV as a long-wave event” was first described by Bar-
nett and Blaikie in 1990 [1]. This idea was developed
further by Barnett and Whiteside who conceptualized
the long-wave nature of HIV in the three curves
depicted in Figure 1 [2]. In general, epidemics follow an
S-curve (see the S-curve on the left in Figure 1). They
start slowly and gradually. When a critical mass of
infected people is reached, the growth of new infections
accelerates (see the steep climb in the middle of the S-
curve). The epidemic spreads through the population
until all people who are susceptible have become
infected. In the final stage of the epidemic (where the S-
curve flattens at the top), people are either getting better
or the number of deaths exceeds the number of new
cases such that the total number of people living with
the infection passes its peak and begins to decline. This
decline typically occurs rapidly.
What sets HIV and AIDS apart from other epidemics is
that there are additional curves to consider. The three
curves in Figure 1 were conceived before the widespread
availability of antiretroviral therapy (ART) [1,2]. First is
the HIV curve, which was envisaged to precede a second
curve, the AIDS curve, by 8 to 12 years. For the HIV
curve, in the absence of a cure the only way to leave the
pool of people with infections is by dying. The second
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curve, AIDS, reflected people who were becoming ill and,
often, dying. The third curve represented impacts, which
included orphaning, food insecurity and other societal
concerns.
The innovation in this multi-curve approach was disag-
gregating the idea of a long-wave event into some of its
constituent processes. This orientation drew attention to
the need for long-term engagement in responding to the
HIV epidemic. It also indicated an intergenerational pro-
blem because: (a) one outcome of the disease was
increased orphaning as parents had children and then
died prematurely, leaving those children to possible
insufficient socialization, thus breaking the bond between
generations; (b) inadequately socialized children were
more likely to adopt risky sexual behaviours, thus replen-
ishing the disease susceptible population age cohort [3].
Finally, this conceptualization of HIV as a long-wave
event cautioned that most standard public health inter-
ventions for communicable diseases would be proble-
matic given the ill-fit with funding streams and sheer
magnitude of the problem.
HIV in the era of expanded treatment access
Free public access to life-saving ART became available in
parts of Africa in the mid-2000’s, in contrast to many
resource-rich countries where ART had been available
from 1996. Despite this delayed start, by the end of 2009,
37% of people eligible for ART in sub-Saharan Africa
were receiving treatment, compared with only 2% in
2002. As a result, AIDS-related deaths in Southern Africa
dropped by almost one-fifth between 2004 and 2009 [4].
The advent of widespread access to ART in Southern
Africa marks the dawning of a new era in the history of
HIV as vast numbers of people living with HIV may
expect to live far longer [5]. Indeed, the clinical, immuno-
logic and virologic effects of ART for people living with
HIV in resource-poor countries are well-documented
[6-8]. Most people who can access and adhere to treat-
ment can expect improvements in CD4 count and viral
load, fewer opportunistic infections and overall reduc-
tions in HIV-related morbidity and mortality. HIV in
high-prevalence, resource-poor countries is on the path
toward becoming a chronic illness [9,10].
This increasing chronicity prompts revisiting HIV as a
long-wave event. First, the advent of widespread ART
means that the HIV curve will be higher and will last
longer since people continue to become HIV-infected
but are also living longer on treatment [11]. As a result,
progression to AIDS on an individual level is far less
predictable, although estimates can be made of treat-
ment failure at a population level. The advent of better
drugs at lower prices, especially second-line regimens,
could further change the shape of the curve.
If patterns in sub-Saharan Africa mirror experiences in
high-income countries, people on ART will live far
longer lives but with new experiences of disability
[12-18]. Disability, broadly defined, can result from HIV,
its related conditions, and from side effects of the medi-
cations [19]. This shifting experience has stimulated
innovative responses from rehabilitation, health and
social sectors in many resource-rich countries [20-25].
However, it is likely that HIV-related disabilities in
resource-poor settings will be more acutely disabling
given the limited availability of rehabilitation, chronic
health care services and social support grants.
Individual experiences of disability will vary greatly. At
a population level, we anticipate that disability will
become a common part of living with HIV, and may now
be understood as a new version of the second curve.
Whereas the second curve in the original conceptualiza-
tion represented the transition to AIDS, in the era of
treatment we can expect a transition from HIV infection
to HIV-related disability for people who can access and
tolerate ART. Many of these individuals may eventually
transition to AIDS as well, but after a potentially long life
that includes fluctuating experiences of illness, wellness
and disability over time. This shift occurs in a milieu
where increased resources are unlikely to be available in
significantly greater quantities than they are now to sup-
port these elevated demands in terms of health infra-
structure, rehabilitation and disability services, palliative
care provision and/or medications to mitigate the effects
of chronically disabling conditions.
Figure 1 The three HIV epidemic curves.
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HIV-related disability
ART has the potential to change HIV from a terminal dis-
ease to a chronic, albeit very serious, illness. This shift
toward chronicity has significant implications for health
and health care, and requires a parallel shift in thinking.
How might we understand and anticipate the second wave
of HIV-related disability? The word disability frequently
invokes static and narrowly-conceived stereotypes. A
broader understanding of disability as far-reaching and
dynamic reflects a more realistic and constructive sce-
nario. A widely-accepted model that provides guidance on
such a broader understanding of disability is the World
Health Organization’s International Classification of Func-
tioning, Disability and Health (ICF) (see Figure 2) [26,27].
The ICF describes diverse dimensions of human function-
ing affected by a health condition, including both biomedi-
cal and social concerns. In contrast to a biomedical
approach that centres on diagnoses and symptoms, the
ICF also focuses on the impact of these diagnoses at three
levels: body structure and function (whereby impairments
are challenges at the level of the body part or structure),
activity (whereby activity limitations are challenges at the
level of the whole person) and participation (whereby par-
ticipation restrictions are challenges faced by the person in
her environment or society). Challenges at all of these
levels may be conceptualized as forms of disability. The
ICF also understands personal and environmental contex-
tual factors as shaping experiences at these three levels.
The ICF has been widely used in both resource-rich
and resource-constrained settings for considering the dis-
ability dimensions of many health conditions [28,29].
Applied to HIV, impairments, activity limitations and
participation restrictions can result from a diverse range
of HIV-associated conditions affecting all body systems,
including neurological and neurocognitive conditions
resulting in brain or spinal cord problems, cardiovascular
system changes resulting in strokes or heart attacks,
musculoskeletal problems related to osteoarthritis and
accelerated osteoporosis, and problems with vision or
hearing. The strength of the ICF is its concern not only
with these diagnoses, but with how these conditions
affect people’s lives and livelihoods. Disability resulting
from HIV-related mental health conditions and neuro-
cognitive changes [30] is also becoming better under-
stood among people living with HIV in Africa, especially
as it is pertains to elevated rates of depression [31].
Other mental health conditions with higher prevalence
among people living with HIV in some African settings
include bipolar disorder, schizophrenia, anxiety, post-
traumatic stress disorder and sleep disorders [32]. Con-
siderable disability can also result from the side effects of
ART such as peripheral neuropathies linked to some
medications, which can create pain and altered sensation
in people’s legs (impairment), potentially limiting their
mobility (activity limitation), thus compromising their
engagement in work or managing a household (participa-
tion restriction). Furthermore, the concept of “environ-
mental contextual factors” within the ICF offers a link to
the social, political and economic forces that may shape
an individuals’ experience of HIV-related disability, such
as the profoundly important role of stigmatizing attitudes
in creating and/or exacerbating disability.
The ICF has been used to conceptualize HIV in coun-
tries like Canada since the advent of ART in the late
1990’s [23,33,34]; however, engagement with this frame-
work for HIV in resource-poor settings has only recently
begun. In 2009, Myezwa and colleagues used the ICF as
the basis for a cross-sectional study that demonstrated a
high level of disablement among 80 HIV-positive hospital
inpatients [35] and among 45 HIV-positive outpatients in
South Africa [36]. Even more recently, Myezwa et al.
compared data from four cross-sectional studies (3 in
South Africa, 1 in Brazil) that had applied the ICF as a
classification instrument to people living with various
stages of HIV and unequal access to ART [37]. Issues
across all groups included weight maintenance and pro-
blems with sleep (50%, 92/185), energy and drive (45%,
83/185), and emotional functions (49%, 90/185). People
on ART identified body image as a major problem. Other
groups reported pain as a problem, and those with lim-
ited access to treatment also reported mobility problems.
Cardiopulmonary functions were affected in all groups.
Gaidhane et al. used the ICF to examine self-care among
194 people living with HIV in a tertiary care hospital in
rural India, finding that over 65% of participants experi-
ences one or more impairments [38]. This early evidence
points to the spectrum of disability that we locate as the
new second curve in the long-wave event of HIV.
Looking ahead
The advent of ART in resource-poor settings has
marked a dramatic shift in the epidemic giving rise to
Figure 2 The World Health Organization’s International
Classification of Functioning, Disability and Health (ICF).
Nixon et al. Globalization and Health 2011, 7:41
http://www.globalizationandhealth.com/content/7/1/41
Page 3 of 5
the potential onset of vastly elevated levels of HIV-
related disability. Indeed, clinicians working in HIV may
be familiar with patients whose clinical markers (e.g.,
CD4 count and viral load) indicate that they are doing
well, yet they are struggling to manage. The reverse can
also be true. This disconnect points to the importance
of considering not only biomedical concerns (e.g., diag-
noses, clinical markers, symptoms, drugs) but also the
life-related impacts of HIV and its related conditions,
which we term HIV-related disability. This shift also
occurred in resource-rich countries in the 1990’s upon
the advent of treatment in those settings. However, the
experience in Africa will be distinct in at least two
important ways. First, the scope of the problem in terms
of both absolute numbers and prevalence in many Afri-
can countries dwarfs the experiences of many resource-
rich countries. Second, the service delivery models for
addressing disability-related concerns are stretched, fra-
gile or non-existent in many African settings.
This analysis is reminiscent of the policy challenges
flagged by Barnett and Blaikie in 1990 regarding the mag-
nitude of the problem and the insufficient preparedness of
the health system for responding to impending needs.
Locating disability as a new form of the second curve in
the long-wave event illuminates this concern today and in
the future. It opens up new thinking about longer-term
responses to these challenges in the era of ART. For exam-
ple, reconceptualizing HIV using a disability lens high-
lights the need for engagement and education of many
social sectors, some of whom may not as yet be engaged
in the HIV response. This will include people involved in
rehabilitation and/or disability efforts at the community,
clinical practice, and policy levels [39]. The recently
released World Report on Disability advocates for the
adoption of the ICF as a universal framework for disability
data collection across health conditions, offering a useful
starting point as the HIV field shifts to consider HIV-
related disability [27]. In terms of health systems, attend-
ing to the increasingly chronic nature of HIV offers links
to existing efforts to recognize and address the increasing
burden of chronic diseases [40]. Finally, national strategic
plans to address HIV also need to take into account HIV-
related disability and the diverse policy and programme
responses required to address these coming changes in the
experience of the disease [41]. Disability will affect many
people living with HIV in the years and decades ahead,
and concomitant responses from health, social and other
sectors will be central to promoting health, quality of life
and productivity.
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